[Form 4] ORASURE TECHNOLOGIES INC Insider Trading Activity

Rhea-AI Filing Summary

OraSure Technologies (OSUR) director John P. Kenny received 6,118 restricted shares on 09/24/2025 under the company's Stock Award Plan in lieu of cash fees. The shares were granted at an indicated price of $3.269 and vest immediately, increasing Mr. Kenny's beneficial ownership to 153,322 shares. The Form 4 was signed by an attorney-in-fact on 09/26/2025. The filing records this as a non-derivative acquisition and specifies the grant was made under the company plan as compensation for director fees.

Positive

• Director aligned with shareholders by accepting equity in lieu of cash fees, increasing insider ownership to 153,322 shares
• Immediate vesting eliminates future vesting contingencies, making the director's stake fully vested and reportable

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Director received immediately vested restricted shares as fee compensation, reflecting routine equity-based director pay.

This transaction is a standard governance practice where a director elects equity in lieu of cash fees. Immediate vesting removes holding conditions, increasing reported beneficial ownership to 153,322 shares and potentially aligning the director's interests with shareholders. The size of the grant (6,118 shares) should be evaluated relative to total outstanding shares and prior holdings to assess materiality, but the filing itself is a routine Section 16 disclosure.

Securities Analyst

TL;DR: Non-derivative grant recorded at $3.269 per share; routine compensation disclosure with no new debt or derivative exposure.

The Form 4 shows a non-derivative acquisition priced at $3.269 and immediate vesting. This increases the director's reported stake to 153,322 shares. From a market perspective, the filing documents compensation via equity rather than cash, which modestly increases share count held by insiders but does not introduce convertible instruments or options. There is no information in the filing about total dilution, company buybacks, or sale intentions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Kenny John P.

(Last) (First) (Middle)

C/O ORASURE TECHNOLOGIES, INC.

220 EAST FIRST STREET

(Street)

BETHLEHEM PA 18015

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ORASURE TECHNOLOGIES INC [ OSUR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/24/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/24/2025		A		6,118(1)	A	$3.269	153,322	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of restricted shares under the OraSure Technologies, Inc. Stock Award Plan in lieu of cash fees with immediate vesting.

	/s/ Michele Anthony, Attorney-in-Fact	09/26/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did OSUR director John P. Kenny acquire on 09/24/2025?

He received 6,118 restricted shares granted under the OraSure Technologies, Inc. Stock Award Plan.

At what price were the shares granted in the OSUR Form 4?

The Form 4 lists a price of $3.269 for the grant.

How many OSUR shares does the reporting person beneficially own after the transaction?

Following the reported transaction the reporting person beneficially owns 153,322 shares.

Did the restricted shares granted to the OSUR director vest immediately?

Yes, the filing explains the grant was made with immediate vesting.

Was this Form 4 filed by one reporting person or jointly?

The filing indicates it was a Form filed by one reporting person.